Skip to main content
Erschienen in: Clinical Orthopaedics and Related Research® 10/2009

01.10.2009 | 50 Years Ago in CORR

50 Years Ago in CORR: A Clinical Study of 46 Males With Low-Back Disorders Treated with Methocarbamol Andres Grisolia MD and J.E.M. Thomson CORR 1959;13:299–304

verfasst von: Richard A. Brand, MD

Erschienen in: Clinical Orthopaedics and Related Research® | Ausgabe 10/2009

Einloggen, um Zugang zu erhalten

Excerpt

The double-blind, randomized control trial (in which neither the patient nor the observer knows the treatments, each of which is administered randomly) is considered the gold standard of designs to determine the results of treatment on patients. The concept of a placebo-controlled trial is not new. None other than Benjamin Franklin proposed what is considered the first placebo controlled trial in the 1780s [7], although the experiments were only single-blinded (the subject was unaware of the treatment). Mesmerism, the invention of Anton Mesmer of Austria, was based on the concept that all illness was caused by a blockage of the body’s natural flow and that magnetism (which Mesmer presumed was some sort of ultrafine fluid) restored the flow and health. Mesmer distinguished mineral and animal magnetism, and suggested the latter had curative properties while the former did not. Many of those exposed to his treatments went into trance-like or even sometimes convulsive states. Mesmer was forced out of Vienna as a charlatan, but then enchanted much of Paris. In 1874, King Louis XVI commissioned the Royal Academy of Medicine and the Academy of Sciences to study the matter. The nine commissioners (including Joseph-Ignace Guillotin, who had developed a “humane” method of execution, and Antoine Lavoisier) engaged Benjamin Franklin, who was living at the time as an ambassador of the United States to France, and one of the world’s most famous scientists [3]. At Franklin’s suggestion they devised an experiment in which the subject was blindfolded and unaware of whether they were exposed to any source of magnetism. The Royal Commission concluded, “…only one cause is requisite to one effect, and that since the imagination is sufficient cause, the supposition of the magnetic fluid is useless. In all of these experiments no differences were found other than those due to varying degrees of imagination” [7]. Franklin wrote to an individual seeking his opinion on the matter, “There being so many disorders which cure themselves and such a disposition in mankind to deceive themselves and one another on these occasions…That delusion may however in some cases be of use while it lasts…If these people can be persuaded to forbear their drugs in expectation of being cured…they may possibly find good effects tho’ they mistake the cause” [7]. …
Literatur
1.
Zurück zum Zitat Altman DG. Better reporting of randomised controlled trials: the CONSORT statement. BMJ. 1996;313:570–571.PubMed Altman DG. Better reporting of randomised controlled trials: the CONSORT statement. BMJ. 1996;313:570–571.PubMed
2.
Zurück zum Zitat Best MA, Neuhauser D, Slavin L. Benjamin Franklin: Verification & Validation of The Scientific Process in Healthcare. Bloomington, IN: Trafford Publishing; 2003. Best MA, Neuhauser D, Slavin L. Benjamin Franklin: Verification & Validation of The Scientific Process in Healthcare. Bloomington, IN: Trafford Publishing; 2003.
3.
Zurück zum Zitat Chan S, Bhandari M. The quality of reporting of orthopaedic randomized trials with use of a checklist for nonpharmacological therapies. J Bone Joint Surg Am. 2007;89:1970–1978.PubMedCrossRef Chan S, Bhandari M. The quality of reporting of orthopaedic randomized trials with use of a checklist for nonpharmacological therapies. J Bone Joint Surg Am. 2007;89:1970–1978.PubMedCrossRef
5.
Zurück zum Zitat Fung AE, Palanki R, Bakri SJ, Depperschmidt E, Gibson A. Applying the CONSORT and STROBE statements to evaluate the reporting quality of neovascular age-related macular degeneration studies. Ophthalmology. 2009;116:286–296.PubMedCrossRef Fung AE, Palanki R, Bakri SJ, Depperschmidt E, Gibson A. Applying the CONSORT and STROBE statements to evaluate the reporting quality of neovascular age-related macular degeneration studies. Ophthalmology. 2009;116:286–296.PubMedCrossRef
6.
Zurück zum Zitat Grant JM. Consort with CONSORT. Consolidation of the Standards of Reporting of Randomised Trials. Br J Obstet Gynaecol. 1996;103:vii. Grant JM. Consort with CONSORT. Consolidation of the Standards of Reporting of Randomised Trials. Br J Obstet Gynaecol. 1996;103:vii.
7.
Zurück zum Zitat Green SA. Dear Doctor Franklin: E-mails to a Founding Father about Science, Medicine, and Technology. Collingdale, PA: Diane Publishing Company; 2008. Green SA. Dear Doctor Franklin: E-mails to a Founding Father about Science, Medicine, and Technology. Collingdale, PA: Diane Publishing Company; 2008.
8.
Zurück zum Zitat Grisolia A, Thomson JEM. A clinical study of 46 males with low-back disorders treated with methocarbamol. Clin Orthop Relat Res. 1959;13:299–304. Grisolia A, Thomson JEM. A clinical study of 46 males with low-back disorders treated with methocarbamol. Clin Orthop Relat Res. 1959;13:299–304.
9.
Zurück zum Zitat Knobloch K, Gohritz A, Vogt PM. CONSORT and QUOROM statements revisited: standards of reporting of randomized controlled trials in general surgery. Ann Surg. 2008;248:1106–1107; discussion 1107–1108. Knobloch K, Gohritz A, Vogt PM. CONSORT and QUOROM statements revisited: standards of reporting of randomized controlled trials in general surgery. Ann Surg. 2008;248:1106–1107; discussion 1107–1108.
10.
Zurück zum Zitat Moseley JB, O’Malley K, Petersen NJ, Menke TJ, Brody BA, Kuykendall DH, Hollingsworth JC, Ashton CM, Wray NP. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med. 2002;347:81–88.PubMedCrossRef Moseley JB, O’Malley K, Petersen NJ, Menke TJ, Brody BA, Kuykendall DH, Hollingsworth JC, Ashton CM, Wray NP. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med. 2002;347:81–88.PubMedCrossRef
Metadaten
Titel
50 Years Ago in CORR: A Clinical Study of 46 Males With Low-Back Disorders Treated with Methocarbamol Andres Grisolia MD and J.E.M. Thomson CORR 1959;13:299–304
verfasst von
Richard A. Brand, MD
Publikationsdatum
01.10.2009
Verlag
Springer-Verlag
Erschienen in
Clinical Orthopaedics and Related Research® / Ausgabe 10/2009
Print ISSN: 0009-921X
Elektronische ISSN: 1528-1132
DOI
https://doi.org/10.1007/s11999-009-1002-8

Weitere Artikel der Ausgabe 10/2009

Clinical Orthopaedics and Related Research® 10/2009 Zur Ausgabe

Symposium: ABJS Carl T. Brighton Workshop on Health Policy Issues in Orthopaedic Surgery

Executive Summary: Aligning Stakeholder Incentives in Orthopaedics

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.